CBD company Chanelle McCoy Health has received approval to start a trial which may allow it to sell its CBD sleeping aid as an over-the-counter (OTC) drug in Australian pharmacies.

The British brand has received ethics approval to begin the third and last phase of an efficacy clinical trial before its synthetic CBD formulation can be marketed in Australia as a non-prescription treatment for sleeping difficulties No CBD product has so far received authorisation to be sold as an OTC medicine in pharmacies in Australia.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

VIEW REPORTS

Request a free sample of this report:

“ Aussie approval puts Chanelle McCoy on the way toward OTC sleeping aid sales ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ Aussie approval puts Chanelle McCoy on the way toward OTC sleeping aid sales ”






      CBD company Chanelle McCoy Health has received approval to start a trial which may allow it to sell its CBD sleeping aid as an over-the-counter (OTC) drug in Australian pharmacies.

      The British brand has received ethics approval to begin the third and last phase of an efficacy clinical trial before its synthetic CBD formulation can be marketed in Australia as a non-prescription treatment for sleeping difficulties No CBD product has so far received authorisation to be sold as an OTC medicine in pharmacies in Australia.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik